Intensive Urate Lowering Therapy of Febuxostat Compared to Allopurinol on Cardiovascular Risk in Patients With Gout

PHASE4CompletedINTERVENTIONAL
Enrollment

196

Participants

Timeline

Start Date

August 17, 2015

Primary Completion Date

May 10, 2017

Study Completion Date

May 10, 2017

Conditions
Gout
Interventions
DRUG

Febuxostat 80/120mg/day

Starting dose and dose regimen of Febuxostat : the initial daily dose is 80 mg. In case the patient has the serum urate concentration \> 6 mg/dl after 2 weeks of treatment the dose will be escalated to 120 mg and if tolerated will be maintained for the duration of the study.

DRUG

Allopurinol 100 up to 600mg/day

Starting dose and dose regimen of allopurinol : the initial daily allopurinol dose is 100 mg, to be increased by 100 mg every 2 weeks in patients with serum urate concentration \>6 mg/dl. The maximum daily dose of allopurinol achievable in the study will depend on kidney function and tolerability, but will not exceed 600 mg.

DRUG

Colchicine

Colchicine 0.5 mg tablets.To prevent flares in the initial stages of treatment, patients will be treated for at least 6 months with colchicine 0.5 - 1 mg QD

DRUG

Naproxen

Naproxen sodium 550 mg film coated tablets. In case of colchicine intolerance patients will be treated for at least 6 months with Naproxen 550 mg BID and Omeprazole (20-40 mg once daily), if indicated to be used.

DRUG

Omeprazole

Omeprazole 20 mg capsules, co-administered to patients for gastric protection.

Trial Locations (26)

1056

Reade Clinic, Amsterdam

40138

Azienda Ospedaliero-Universitaria Policlinico Sant'Orsola-Malpighi, Bologna

66100

"Ospedale Policlinico SS. Annunziata Università degli Studi G. d'Annunzio. Dipartimento di Medicina e Scienze dell'Invecchiamento.", Chieti

67051

Presidio Ospedaliero San Filippo e Nicola Università degli Studi dell'Aquila U.O.C Geriatria e Lungodegenza Geriatrica, Avezzano

67100

Ospedale San Salvatore U.O.C. Medicina Interna e Nefrologia Dipartimento MeSVA Università degli Studi dell'Aquila, Coppito

01307

"Medizinische Klinik und Poliklinik III/Rheumatologie Universitätsklinikum Carl Gustav Carus Der Technischen Universität", Dresden

Unknown

Gdańskie Centrum Zdrowia Sp.z o.o., Gdansk

Specjalistyczna Praktyka Lekarska Piotr Kubalski, Grudziądz

Centrum Medyczne Pratia Katowice, Katowice

Centrum Medyczne Plejady, Krakow

Krakowski Szpital Specjalistyczny im. Jana Pawła II w Krakowie, Krakow

Specjalistyczny Gabinet Dermatologiczno-Kosmetyczny, Krakow

Oddział Kardiologiczny, WSS im. W. Biegańskiego w Łodzi, Lodz

Polimedica, Lodz

Pratia S,A, Warsaw

Reumatika- Centrum Reumatologii, Warsaw

S.C. Centrul Medical Sana S.R.L., Bucharest

S.C. Cardiomed S.R.L., Craiova

Cabinet Medical Medicina Interna, Timișoara

Institutul de Boli Cardiovasculare Clinica de Cardiologie si Recuperare Cardiovasculara, Timișoara

Institut za kardiovaskularne bolesti Dedinje, Belgrade

Institut za reumatologiju, Belgrade

"Kliničko-bolnički centar Bežanijska kosa Klinika za imunologiju i alergologiju", Belgrade

Vojnomedicinska akademija Klinika za reumatologiju, Belgrade

Sector 1

Clinica Medicală Data Plus SRL, Bucharest

Sector 2

Institutul Clinic Fundeni, Bucharest

All Listed Sponsors
lead

Menarini International Operations Luxembourg SA

INDUSTRY

NCT02500641 - Intensive Urate Lowering Therapy of Febuxostat Compared to Allopurinol on Cardiovascular Risk in Patients With Gout | Biotech Hunter | Biotech Hunter